Viscosupplementation sales will expand through 2036, with three injection knee hyaluronic acid injections at 47.8% of product demand and ambulatory surgical centers at 32.3% of end user sales in 2026. The market is estimated at USD 2,410.2 million in 2026 and is forecast to record a 5.7% CAGR between 2026 and 2036.